Literature DB >> 31414299

Potential Use of Exfoliated and Cultured Olfactory Neuronal Precursors for In Vivo Alzheimer's Disease Diagnosis: A Pilot Study.

Agustín Riquelme1,2, Marcela Valdés-Tovar1, Oscar Ugalde3, Vanessa Maya-Ampudia1, Monserrat Fernández3, Leticia Mendoza-Durán1, Leslye Rodríguez-Cárdenas1, Gloria Benítez-King4.   

Abstract

Histopathological hallmarks of dementia have been described postmortem in the brain of patients with Alzheimer's disease (AD). Tau, a microtubule associated protein, is abnormally arranged in neurofibrillary tangles. In living AD patients, total tau (t-tau) and hyperphosphorylated tau (p-tau) levels are increased in the cerebrospinal fluid obtained by lumbar puncture. Herein, we studied the t-tau and p-tau levels as well as the subcellular distribution of t-tau in olfactory neuronal precursors obtained by exfoliation of the nasal cavity of AD patients and control participants. Data showed that t-tau and p-tau levels were increased in cell homogenates from AD patients. Also, t-tau immunoreactivity was arranged in a punctate pattern in olfactory neuronal precursors derived from an AD participant with 5 years of evolution and in the oldest participants, either control subjects or those with Alzheimer's disease. Results support that exfoliated neuronal precursors have tau alterations demonstrated in postmortem brain and in the cerebrospinal fluid. This evidence and because the obtainment of olfactory neuronal precursors is a noninvasive procedure, detection of tau alterations shown here might be useful for an early diagnosis of AD-type dementia.

Entities:  

Keywords:  Alzheimer’s disease; Olfactory neuronal precursors; Phospho-tau; Tau

Mesh:

Substances:

Year:  2019        PMID: 31414299     DOI: 10.1007/s10571-019-00718-z

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  59 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. 1979.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Biotechnology       Date:  1992

Review 2.  Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders.

Authors:  Tibor Kovács
Journal:  Ageing Res Rev       Date:  2004-04       Impact factor: 10.895

Review 3.  Tau pathology in Alzheimer disease and other tauopathies.

Authors:  Khalid Iqbal; Alejandra del C Alonso; She Chen; M Omar Chohan; Ezzat El-Akkad; Cheng-Xin Gong; Sabiha Khatoon; Bin Li; Fei Liu; Abdur Rahman; Hitoshi Tanimukai; Inge Grundke-Iqbal
Journal:  Biochim Biophys Acta       Date:  2005-01-03

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 5.  The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment.

Authors:  Rawan Tarawneh; David M Holtzman
Journal:  Cold Spring Harb Perspect Med       Date:  2012-05       Impact factor: 6.915

6.  Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.

Authors:  Jean C Augustinack; Anja Schneider; Eva-Maria Mandelkow; Bradley T Hyman
Journal:  Acta Neuropathol       Date:  2002-01       Impact factor: 17.088

7.  Early olfactory involvement in Alzheimer's disease.

Authors:  S Christen-Zaech; R Kraftsik; O Pillevuit; M Kiraly; R Martins; K Khalili; J Miklossy
Journal:  Can J Neurol Sci       Date:  2003-02       Impact factor: 2.104

8.  Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay.

Authors:  M Vandermeeren; M Mercken; E Vanmechelen; J Six; A van de Voorde; J J Martin; P Cras
Journal:  J Neurochem       Date:  1993-11       Impact factor: 5.372

9.  A population-based study of tau protein and ubiquitin in cerebrospinal fluid in 85-year-olds: relation to severity of dementia and cerebral atrophy, but not to the apolipoprotein E4 allele.

Authors:  I Skoog; E Vanmechelen; L A Andreasson; B Palmertz; P Davidsson; C Hesse; K Blennow
Journal:  Neurodegeneration       Date:  1995-12

10.  Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.

Authors:  Heiko Braak; Irina Alafuzoff; Thomas Arzberger; Hans Kretzschmar; Kelly Del Tredici
Journal:  Acta Neuropathol       Date:  2006-08-12       Impact factor: 17.088

View more
  3 in total

1.  Proteomic Analysis of patients with Epileptic Seizure and Psychogenic Non-epileptic Seizure; a Cross-Sectional Study.

Authors:  Mohsen Parvareshi Hamrah; Mostafa Rezaei Tavirani; Monireh Movahedi; Sanaz Ahmadi Karvigh
Journal:  Arch Acad Emerg Med       Date:  2020-03-11

2.  Antidepressant Low Doses of Ketamine and Melatonin in Combination Produce Additive Neurogenesis in Human Olfactory Neuronal Precursors.

Authors:  Rosa Estrada-Reyes; Daniel B Quero-Chávez; Salvador Alarcón-Elizalde; Montserrat G Cercós; Citlali Trueta; Luis A Constantino-Jonapa; Julián Oikawa-Sala; Jesús Argueta; Ricardo Cruz-Garduño; Margarita L Dubocovich; Gloria A Benítez-King
Journal:  Molecules       Date:  2022-09-01       Impact factor: 4.927

Review 3.  Analyzing Olfactory Neuron Precursors Non-Invasively Isolated through NADH FLIM as a Potential Tool to Study Oxidative Stress in Alzheimer's Disease.

Authors:  Laura Gómez-Virgilio; Alejandro Luarte; Daniela P Ponce; Bárbara A Bruna; María I Behrens
Journal:  Int J Mol Sci       Date:  2021-06-12       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.